[Effect of thymosin alpha1 on immunological function and metabolism in peritoneal sepsis rats].
Jiang. Jun J; Li. Ning N; Li. Jie-Shou JS
Key Findings
- Thymosin‑alpha‑1 lowered TNF‑α and IL‑6 and raised IL‑10 in septic rats
- It increased CD3, CD4 and the CD4/CD8 ratio, indicating better T‑cell function
- It reduced albumin loss, lowered CRP rise, and cut 7‑day mortality
Practical Outcomes
- The data show thymosin‑alpha‑1 can modulate immune response and improve survival in severe infection in animals, but there’s no human evidence yet. For biohackers, it’s not a ready‑to‑use supplement for longevity or performance, and dosing or safety in healthy people remains unknown. More clinical research is needed before practical protocols can be recommended.
Summary
In a rat study, giving thymosin‑alpha‑1 after a severe abdominal infection lowered harmful inflammation markers, boosted anti‑inflammatory signals and T‑cell numbers, helped keep protein levels up, and cut the death rate over a week.
Abstract
To investigate the effect of thymosin alpha1 on immunological function and protein metabolism in peritoneal sepsis rats. We observed the effect of thymosin alpha1 on T cell subclassification, TNFalpha, IL-6, IL-10, albumin, C-reactive protein (CRP) and mortality in cecal ligation and puncture (CLP) induced septic rats. Concentration of TNFalpha and IL-6 in CLP induced septic rats increased significantly, and concentration of IL-10 decreased significantly compared to control group. Thymosin alpha1 significantly decreased TNFalpha, IL-6, and significantly raised concentration of plasma IL-10, percent of CD(3), CD(4), and CD(4)/CD(8) in septic group. Thymosin alpha1 reduced degressive degree of albumin. Concentration of CRP increased in both septic groups, but was less prominently in thymosin alpha1 treated group. Thymosin alpha1 reduced cumulate 7-day mortality. Thymosin alpha1 can improve immunological function, inflammation condition and protein metabolism.
Study Information
pubmed
2004
2004-11-22T00:00:00.000Z